Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.
Rosario M, French JL, Dirks NL, Sankoh S, Parikh A, Yang H, Danese S, Colombel JF, Smyth M, Sandborn WJ, Feagan BG, Reinisch W, Sands BE, Sans M, Fox I.
Rosario M, et al. Among authors: dirks nl.
J Crohns Colitis. 2017 Aug 1;11(8):921-929. doi: 10.1093/ecco-jcc/jjx021.
J Crohns Colitis. 2017.
PMID: 28333288
Clinical Trial.